Medicare Enrolled

Dr. Victoria Chin, O.D., MBA

Optometrist · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5115 MAIN ST, Houston, TX 77002
7135802500
In practice since 2006 (19 years)
NPI: 1184738536 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chin

Dr. Victoria Chin is an optometrist in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Chin performed 685 Medicare services across 549 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chin received a total of $16,012 from 37 pharmaceutical and/or device companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in TX$ $16,012 industry payments

Medicare Practice Summary

Medicare Utilization ↗
685
Medicare services
Top 17% in TX for optometrist
549
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~36 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)130$90$250
Office visit, established patient (20-29 min)107$67$154
Comprehensive eye exam, established patient90$77$195
Retinal imaging (OCT scan)66$28$108
Optic nerve imaging (OCT scan)56$22$100
Visual field test, extended55$47$150
Analysis of substance using immunoassay technique, multiple step method41$11$25
Retinal photography (fundus photo)32$29$110
Photography of content of eyes32$18$74
New patient office visit (45-59 min)19$100$341
Ultrasound scan of cornea to determine thickness15$8$35
Ct scan of cornea15$29$95
Office visit, established patient (10-19 min)15$46$100
Comprehensive eye exam, new patient12$104$221
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,012
Total received (2018-2024)
Avg $2,287/year across 7 years
Top 2% in TX for optometrist
37
Companies
440
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,558 (90.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,454 (9.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,695
2023
$2,467
2022
$2,665
2021
$2,326
2020
$827
2019
$2,103
2018
$1,929

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$1,733
Tarsus Pharmaceuticals, Inc.
$1,454
ABBVIE INC.
$1,272
Allergan, Inc.
$1,178
The Walman Optical Company
$1,160
Sun Pharmaceutical Industries Inc.
$946
Allergan Inc.
$851
Alcon Laboratories Inc
$690
AbbVie Inc.
$642
Novartis Pharmaceuticals Corporation
$609
Bausch & Lomb Americas Inc.
$487
Oyster Point Pharma, Inc.
$472
BioTissue Holdings, Inc.
$429
Shire North American Group Inc
$398
Sight Sciences, Inc.
$376
SUN PHARMACEUTICAL INDUSTRIES INC.
$345
Dompe US, Inc.
$341
Johnson & Johnson Surgical Vision, Inc.
$336
TissueTech, Inc.
$281
Bausch & Lomb, a division of Bausch Health US, LLC
$258
Kala Pharmaceuticals, Inc.
$240
Eyevance Pharmaceuticals LLC
$232
Carl Zeiss Meditec USA, Inc.
$204
Amgen Inc.
$190
Johnson & Johnson Vision Care, Inc.
$152
BIOTISSUE HOLDINGS INC.
$151
BIOTISSUE HOLDINGS, INC.
$134
Horizon Therapeutics plc
$98
Quidel Corporation
$67
TearLab Corp
$63
Astellas Pharma US Inc
$58
Aerie Pharmaceuticals, Inc.
$46
MacuLogix, Inc.
$33
Harrow Eye, LLC
$30
CooperVision Inc.
$26
Derma Sciences, Inc.
$17
TOPCON HEALTHCARE SOLUTIONS, INC.
$13
Top 3 companies account for 27.8% of total payments
Associated products mentioned in payments ›
ACTIVEFOCUS · ALDEN SCLERAL ZENLENS · ALPHAGAN P · AcrySof · Acuvue · AdaptDx · Atlantis · BIOFIX · BROMSITE · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · Cequa · Clareon · DAILIES · DAILIES TOTAL1 · DURYSTA · EYSUVIS · Eye Health · Flarex · HARMONY · HYDRUS Microstent · INFUSE · INVELTYS · Izervay · LOTEMAX · LUMIGAN · MIEBO · MyDay Contact Lens · OXERVATE · Optimum Extra · Oxervate · PROKERA · Precision 1 · Prokera · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · Rhopressa · Rocklatan · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TOTAL30 · TYRVAYA · TearCare · TearCare SmartLid · TearLab Osmolarity System · Tecnis 1-piece IOL · Tobradex ST · ULTRA · VEVYE · VUITY · VYZULTA · WaveLight EX500 Excimer Laser · Wavelight · Wavelight Refractive Suite · XDEMVY · XELPROS · XIIDRA · ZYLET · Zerviate · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for optometrist in TX.

Equivalent to $2,338 per 100 Medicare services performed
Looking for a optometrist in Houston?
Compare optometrists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
1,197
Per 100K population
25.2
County median income
$73,104
Nearest hospital
ST JOSEPH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chin is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chin performed 130 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chin receive payments from pharmaceutical companies?
Yes. Dr. Chin received a total of $16,012 from 37 companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chin's costs compare to other optometrists in Houston?
Dr. Chin's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →